Tedence

Company Overview

Snapshot

Founded in September 2022 by Morris Laster, Tedence operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing an AI-powered therapeutic platform. In September 2023, Tedence was featured for its innovative approach to managing juvenile diabetes.

Business overview

Tedence is an AI-powered healthcare platform focused on developing personalized therapeutic solutions for chronic and autoimmune diseases. The company's core technology utilizes artificial intelligence to create bioelectric treatments delivered through wearable technology. Tedence aims to revolutionize medicine by leveraging the power of frequencies, serving the healthcare and life sciences sectors, with a particular focus on patients and the medical devices industry.

Strategic signal

In September 2023, Tedence garnered media attention for its innovative development in addressing juvenile diabetes. This highlights the company's potential to disrupt chronic disease management through its AI-powered bioelectric treatments and wearable technology, signaling a promising trajectory for its therapeutic platform in the health tech sector.

Company Intelligence Q&A

What is Tedence's primary focus?

Tedence focuses on developing an AI-powered personalized therapeutic platform for chronic and autoimmune diseases, utilizing bioelectric treatments delivered via wearable technology.

When was Tedence founded?

Tedence was founded in September 2022.

Who is the founder of Tedence?

Morris Laster is the Founder & CEO of Tedence.

What was a notable development for Tedence in 2023?

In September 2023, Tedence was recognized for its innovative development in addressing juvenile diabetes, as reported by Maariv.

What technology does Tedence leverage?

Tedence leverages artificial intelligence to create its personalized therapeutic platform.